North America Transdermal Drug Delivery Systems Market Size, Share & Industry Trends Analysis Report By Application (Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation), By Type of Delivery System, By Country and G

North America Transdermal Drug Delivery Systems Market Size, Share & Industry Trends Analysis Report By Application (Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation), By Type of Delivery System, By Country and Growth Forecast, 2022 – 2028

The North America Transdermal Drug Delivery Systems Market would witness market growth of 4.0% CAGR during the forecast period (2022-2028).

The term drug delivery system refers to a group of physicochemical techniques that can regulate the distribution and discharge of pharmacologically active chemicals into cells, tissues, and organs so that they can exert their effects as effectively as possible. DDS, therefore, addresses formulations that effectively administer the medicine to optimize therapeutic efficacy while minimizing any negative effects.

There are many different administration methods, including transdermal administration, oral administration, mucosal administration, lung inhalation, and intravenous injection, depending on the delivery route. The TDDS stands out among them as an appealing strategy. The distribution of numerous therapeutic agents has been greatly impacted by TDDS, particularly in the treatment of disorders of the cardiovascular (CVD) and central nervous systems, hormone therapy, and pain management.

Since TDDS avoids the digestive tract, there is no loss from first-pass metabolism, and medications can be administered without being hampered by pH, enzymes, or intestinal flora. The great persistence of this approach is also attributed to the ability of TDDS to manage medication release in accordance with usage limitations.

The trends of using transdermal drug delivery systems are increasing in North America because of factors including rising demand for non-invasive methods of drug delivery, the growing rate of chronic diseases, and high adoption of self-administration of medications. These factors accompanied by growing investments in R&D for the creation of novel drug delivery systems have made the US the largest market in North America for TDDS. In addition, TDDS is also popularizing in this nation as a result of the presence of numerous producers with strong product portfolios and an increase in product approvals for transdermal medication delivery systems.

The US market dominated the North America Transdermal Drug Delivery Systems Market by Country in 2021; thereby, achieving a market value of $20,370.9 million by 2028. The Canada market is experiencing a CAGR of 6.4% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 5.4% during (2022 - 2028).

Based on Application, the market is segmented into Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation and Others. Based on Type of Delivery System, the market is segmented into Passive and Active. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris Inc., Bayer AG, Boehringer Ingelheim GmbH, Endo International plc, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Purdue Pharma L.P., Altaris and Hisamitsu Pharmaceutical Co. Inc.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Analgesics
  • Hormone Replacement Therapies
  • Hypertension
  • Motion Sickness
  • Smoking Cessation
  • Others
By Type of Delivery System
  • Passive
  • Active
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Viatris Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Endo International plc
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Novartis AG
  • Purdue Pharma L.P.
  • Altaris
  • Hisamitsu Pharmaceutical Co. Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Transdermal Drug Delivery Systems Market, by Application
1.4.2 North America Transdermal Drug Delivery Systems Market, by Type of Delivery System
1.4.3 North America Transdermal Drug Delivery Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Transdermal Drug Delivery Systems Market by Application
3.1 North America Analgesics Market by Country
3.2 North America Hormone Replacement Therapies Market by Country
3.3 North America Hypertension Market by Country
3.4 North America Motion Sickness Market by Country
3.5 North America Smoking Cessation Market by Country
3.6 North America Others Market by Country
Chapter 4. North America Transdermal Drug Delivery Systems Market by Type of Delivery System
4.1 North America Passive Market by Country
4.2 North America Active Market by Country
Chapter 5. North America Transdermal Drug Delivery Systems Market by Country
5.1 US Transdermal Drug Delivery Systems Market
5.1.1 US Transdermal Drug Delivery Systems Market by Application
5.1.2 US Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2 Canada Transdermal Drug Delivery Systems Market
5.2.1 Canada Transdermal Drug Delivery Systems Market by Application
5.2.2 Canada Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3 Mexico Transdermal Drug Delivery Systems Market
5.3.1 Mexico Transdermal Drug Delivery Systems Market by Application
5.3.2 Mexico Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4 Rest of North America Transdermal Drug Delivery Systems Market
5.4.1 Rest of North America Transdermal Drug Delivery Systems Market by Application
5.4.2 Rest of North America Transdermal Drug Delivery Systems Market by Type of Delivery System
Chapter 6. Company Profiles
6.1 Viatris, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approval:
6.2 Purdue Pharma L.P.
6.2.1 Company Overview
6.3 Bayer AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Novartis AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Boehringer Ingelheim International Gmbh
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.6 GlaxoSmithKline PLC
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Johnson & Johnson
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental &Regional Analysis
6.7.4 Research & Development Expenses
6.8 Endo International PLC
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Altaris Capital Partners, LLC
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Acquisition and Mergers:
6.10. Hisamitsu Pharmaceutical Co. Inc.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Recent strategies and developments:
6.10.3.1 Approval:

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings